Ingevity/$NGVT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ingevity
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Ticker
$NGVT
Sector
Primary listing
NYSE
Industry
Chemicals
Headquarters
Employees
1,600
ISIN
US45688C1071
Website
Ingevity Metrics
BasicAdvanced
$1.6B
-
-$9.74
1.39
-
Price and volume
Market cap
$1.6B
Beta
1.39
52-week high
$50.09
52-week low
$28.49
Average daily volume
214K
Financial strength
Current ratio
2.003
Quick ratio
0.916
Long term debt to equity
568.031
Total debt to equity
593.777
Interest coverage (TTM)
2.98%
Profitability
EBITDA (TTM)
384.9
Gross margin (TTM)
35.16%
Net profit margin (TTM)
-26.20%
Operating margin (TTM)
21.01%
Effective tax rate (TTM)
19.02%
Revenue per employee (TTM)
$840,000
Management effectiveness
Return on assets (TTM)
7.66%
Return on equity (TTM)
-88.14%
Valuation
Price to revenue (TTM)
1.195
Price to book
6.9
Price to tangible book (TTM)
-7.26
Price to free cash flow (TTM)
16.972
Free cash flow yield (TTM)
5.89%
Free cash flow per share (TTM)
261.61%
Growth
Revenue change (TTM)
-17.64%
Earnings per share change (TTM)
215.11%
3-year revenue growth (CAGR)
-2.44%
10-year revenue growth (CAGR)
2.83%
3-year earnings per share growth (CAGR)
43.74%
10-year earnings per share growth (CAGR)
13.03%
What the Analysts think about Ingevity
Analyst ratings (Buy, Hold, Sell) for Ingevity stock.
Bulls say / Bears say
Ingevity's Performance Materials division achieved record performance in 2024, with margins exceeding 50%, driven by new pricing and operational efficiency initiatives. (stocktitan.net)
The company announced a strategic review of its Industrial Specialties product line and North Charleston CTO refinery, aiming to enhance profitability and shareholder value. (stocktitan.net)
Ingevity's Performance Chemicals segment transformation delivered $84 million in savings in 2024, surpassing their $65-75 million target, with additional savings of $10-25 million expected in 2025. (stocktitan.net)
Ingevity's Q1 2025 revenues fell 16.5% year over year to $284 million, primarily due to lower sales in the Industrial Specialties product line and the Advanced Polymer Technologies segment. (nasdaq.com)
The company reported a net loss of $283.7 million in Q2 2024, compared to a profit of $35.5 million in the year-ago quarter, indicating significant financial challenges. (nasdaq.com)
Ingevity's stock has declined approximately 38% over the past three years, underperforming the market and raising concerns about its long-term growth prospects. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
Ingevity Financial Performance
Revenues and expenses
Ingevity Earnings Performance
Company profitability
Ingevity News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ingevity stock?
Ingevity (NGVT) has a market cap of $1.6B as of July 02, 2025.
What is the P/E ratio for Ingevity stock?
The price to earnings (P/E) ratio for Ingevity (NGVT) stock is 0 as of July 02, 2025.
Does Ingevity stock pay dividends?
No, Ingevity (NGVT) stock does not pay dividends to its shareholders as of July 02, 2025.
When is the next Ingevity dividend payment date?
Ingevity (NGVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Ingevity?
Ingevity (NGVT) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.